Lv51
830 积分 2024-08-14 加入
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions
10天前
已完结
Taletrectinib in ROS1 + Non–Small Cell Lung Cancer: TRUST
10天前
已完结
Precision Immunotherapy for STK11/KEAP1-Mutant NSCLC
14天前
已完结
Ivonescimab in advanced NSCLC: is progression-free survival enough, or are overall survival data also needed?
14天前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
17天前
已完结
Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer
22天前
已完结
Targeting HER2 in lung cancers: Evolving treatment landscape and drug development strategies
23天前
已完结
Optimal management of radiation Pneumonitis: Findings of an international Delphi consensus study
26天前
已完结
Trends in kinase drug discovery: targets, indications and inhibitor design
1个月前
已完结
Structure-Based Macrocycle Design in Small-Molecule Drug Discovery and Simple Metrics To Identify Opportunities for Macrocyclization of Small-Molecule Ligands
1个月前
已完结
皖公网安备34019202002308
